Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00490945
Study type Interventional
Source Vanda Pharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date July 2004
Completion date March 2005

See also
  Status Clinical Trial Phase
Completed NCT02776215 - Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents Phase 1
Suspended NCT00427323 - Light Exposure to Treat Sleep Disruption in Older People N/A